Oppenheimer reaffirmed their outperform rating on shares of Corteva (NYSE:CTVA – Free Report) in a report issued on Friday,Benzinga reports. The firm currently has a $70.00 price objective on the stock, up from their previous price objective of $69.00.
Several other research analysts have also recently weighed in on the stock. Wells Fargo & Company cut their price target on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating on the stock in a report on Friday, August 2nd. Citigroup started coverage on Corteva in a research report on Wednesday, October 23rd. They set a “buy” rating and a $68.00 price target for the company. JPMorgan Chase & Co. cut their price objective on Corteva from $57.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. Argus lowered Corteva from a “buy” rating to a “hold” rating in a research report on Wednesday, August 7th. Finally, KeyCorp cut their price target on shares of Corteva from $66.00 to $62.00 and set an “overweight” rating on the stock in a report on Friday, August 2nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $63.68.
Get Our Latest Research Report on Corteva
Corteva Price Performance
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 1.16%. Corteva’s payout ratio is 68.69%.
Hedge Funds Weigh In On Corteva
A number of hedge funds and other institutional investors have recently modified their holdings of CTVA. Acadian Asset Management LLC bought a new stake in Corteva in the 1st quarter worth approximately $25,000. Capital Advisors Ltd. LLC lifted its holdings in shares of Corteva by 44.4% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock worth $33,000 after acquiring an additional 174 shares during the last quarter. Cultivar Capital Inc. purchased a new stake in shares of Corteva in the 2nd quarter valued at $34,000. Redwood Wealth Management Group LLC bought a new position in shares of Corteva during the 2nd quarter valued at $43,000. Finally, Triad Wealth Partners LLC purchased a new position in Corteva in the 2nd quarter worth $45,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
About Corteva
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading
- Five stocks we like better than Corteva
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What is the FTSE 100 index?
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Short Selling: How to Short a Stock
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.